EUVIMEDEUVIMED entdecken
Open Access

High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda

P Ocama, R Ssekitoleko, J Nankya-Mutyoba, B Apica, G Otekat, E Seremba

African Health Sciences · 2024

DOI: 10.4314/ahs.v24i3.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Health Sciences, 2024. Verfasst von P Ocama und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Hepatitis C, Blood Donors, Hepatitis C Antibodies, Hepacivirus. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Successful elimination of hepatitis as a public health threat by 2030 will partly rely on the availability and accessibility of affordable accurate disease testing platforms. In the past, testing of hepatitis C virus (HCV) in low resource settings of sub-Saharan Africa (SSA) has relied on anti-HCV testing using rapid diagnostic tests, chemiluminescent microparticle immunoassay (CMIA) and Enzyme-linked Immunosorbent Assays (ELISA) whose diagnostic accuracy has been sub-optimal. We determined the false positivity rate of a CMIA platform that is routinely used to screen donor blood for anti-HCV in Uganda.

Methods

1,216 CMIA-screened anti-HCV-positive blood donor samples at four regional Ugandan blood banks, were subjected to a third generation ELISA and subsequently to nucleic acid testing (NAT).

Results

Of the above 1,216 samples, 1,122 (92.2%) were negative on ELISA and thus deemed false positives. Active infection (NAT positive) was detected in 98 (8.0%). Presumed resolved infection was recorded among 3 (3.2%) of participants that remained positive on the ELISA platform but negative on NAT.

Conclusion

The Architect CMIA assay exhibited very low specificity for anti-HCV testing. In this context, this finding may suggest need to employ testing protocols that include NAT or a combination of tests with higher validity. Keywords: High false hepatitis C; antibody positivity rate; non-renumerated blood donors; Uganda.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CBlood DonorsHepatitis C AntibodiesHepacivirusHumansUgandaEnzyme-Linked Immunosorbent AssayFalse Positive ReactionsMaleFemaleAdultSensitivity and SpecificityMass ScreeningMiddle Aged

Stichwörter der Autor:innen

High false hepatitis CUgandaantibody positivity ratenon-renumerated blood donors

Substanzen

Hepatitis C Antibodies

Autor:innen und Institutionen

  • School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
  • Uganda Blood Transfusion Service, Kampala, Uganda.

Zitieren

APA

Ocama, P., Ssekitoleko, R., Nankya-Mutyoba, J., Apica, B., Otekat, G., & Seremba, E. (2024). High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda. African Health Sciences. https://doi.org/10.4314/ahs.v24i3.6

Vancouver

Ocama P, Ssekitoleko R, Nankya-Mutyoba J, Apica B, Otekat G, Seremba E. High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda. African Health Sciences. 2024. doi:10.4314/ahs.v24i3.6

BibTeX
@article{Ocama2024,
  author = {Ocama, P and Ssekitoleko, R and Nankya-Mutyoba, J and Apica, B and Otekat, G and Seremba, E},
  title = {High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda},
  journal = {African Health Sciences},
  year = {2024},
  doi = {10.4314/ahs.v24i3.6}
}
Kostenlos starten →